Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Porcine Vascular endothelial growth factor B (VEGFB) ELISA Kit-Sandwich

Name: Porcine Vascular endothelial growth factor B (VEGFB) ELISA Kit-Sandwich
SKU: EK11F192
Rating: 5 (1 reviews)

Cat. No.EK11F192

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Porcine VEGFB ELISA Kit-Sandwich is designed for the quantitative determination of Porcine VEGFB in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Porcine VEGFB.

Target Species Swine

Species Reactivity Swine

Detection Range 3-200 pg/mL

Sensitivity 0.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids;10 μL

Target Information

Vascular endothelial growth factor B is encoded by the VEGFB gene in pigs. Besides angiogenic effects, VEGF-B also has a protective role in cardiomyocyte metabolism under ischemia.

Target/Biomarker Porcine VEGFB

Target Synonym vascular endothelial growth factor B

Gene ID 100521837

UniProt ID F1RQ05

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Korpela, H. et al. AAV2-VEGF-B gene therapy failed to induce angiogenesis in ischemic porcine myocardium due to inflammatory responses. Gene therapy. 2022, 29: 643-652.